Skeletal Muscle Channelopathies
Gene: CACNB1A single heterozygous case with a positive IVCT muscle biopsy has been reported with p.Val156Ala. The European non-Finnish allele frequency in gnomAD v2.1 is 0.001146 (148/129,118 alleles), which is higher than the expected population frequency for dominantly inherited malignant hyperthermia (0.1%). Additionally, functional assays of this variant, suggest it would only significantly affect function in the homozygous state (suggesting a recessive condition).
Sources: Expert listCreated: 29 Jun 2020, 10:36 a.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Malignant hyperthermia susceptibility
Publications
A single heterozygous case with a positive IVCT muscle biopsy has been reported with p.Val156Ala. The European non-Finnish allele frequency in gnomAD v2.1 is 0.001146 (148/129,118 alleles), which is higher than the expected population frequency for dominantly inherited malignant hyperthermia (0.1%). Additionally, functional assays of this variant, suggest it would only significantly affect function in the homozygous state (suggesting a recessive condition).Created: 29 Jun 2020, 3:20 a.m. | Last Modified: 29 Jun 2020, 3:20 a.m.
Panel Version: 0.5
Mode of inheritance
Unknown
Phenotypes
Malignant hyperthermia
Publications
Gene: cacnb1 has been classified as Red List (Low Evidence).
Gene: cacnb1 has been classified as Red List (Low Evidence).
gene: CACNB1 was added gene: CACNB1 was added to Skeletal Muscle Channelopathies_RMH. Sources: Expert Review Amber,Royal Melbourne Hospital Mode of inheritance for gene: CACNB1 was set to Publications for gene: CACNB1 were set to 27832566; 8943043; 29212769 Phenotypes for gene: CACNB1 were set to ?Malignant hyperthermia susceptibility